Fahed Al-Marzooqi - Feb 27, 2024 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Paul J. Sekhri as Attorney-in-Fact
Stock symbol
VTVT
Transactions as of
Feb 27, 2024
Transactions value $
$47,890
Form type
4
Date filed
6/13/2024, 04:42 PM
Previous filing
Jun 21, 2023
Next filing
Jun 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $47.9K +4.06K +162.2% $11.81 6.56K Feb 27, 2024 Class A Common Stock 4.06K $11.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.